Drug Shortage Report for RAN-NABILONE

Last updated on 2019-02-01 History
Report ID 12334
Drug Identification Number 02358077
Brand name RAN-NABILONE
Common or Proper name RAN-NABILONE
Company Name RANBAXY PHARMACEUTICALS CANADA INC.
Active Ingredient(s) NABILONE
Strength(s) 0.25MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 100
ATC code A04AD
ATC description ANTIEMETICS AND ANTINAUSEANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2017-05-10
Actual start date 2017-05-10
Estimated end date 2017-06-10
Actual end date 2017-12-31
Shortage status Resolved
Updated date 2019-02-01
Company comments Discontinued
Health Canada comments
Contact Address 126 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2019-02-01 French Compare
v3 2019-02-01 English Compare
v2 2017-06-08 French Compare
v1 2017-06-08 English Compare